About Nicholas Gianadda
Form D filings for Quadrant Biosciences in 2023 list Nicholas Gianadda as executive officer.
Nicholas Gianadda first appears on SEC filings in 2023.
Experience
This experience comes from SEC filings. The years are when the filings name Nicholas Gianadda in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people Nicholas Gianadda works with at each company, as listed on that company's latest Form D.
Quadrant Biosciences Inc · Form D, Nov 2, 2023
EA
Erica Ash
Executive officer
JC
James Croke
Executive officer and director
AR
Andrew Rock
Director
PC
Peter Cohen
Director
RB
Richard Bongo
Chief Financial Officer and director
IF
Ira Fedder
Director
MT
Mary Ann Tyszko
Director
BG
Bryan Greene
Executive officer
RU
Richard Uhlig
Executive officer and director